Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SREBF2 FOXJ2 NCOA3 ZNF384 JUN POU6F2 BATF3 ARNT ZNF319 ZNF853 HOXD9 PRDM15 CREBBP MED12 MEF2D	6.75e-09	1459	35	15	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SREBF2 FOXJ2 ZNF384 JUN POU6F2 BATF3 ARNT ZNF319 ZNF853 HOXD9 PRDM15 MED12 MEF2D	8.13e-08	1244	35	13	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SREBF2 FOXJ2 ZNF384 JUN POU6F2 BATF3 ARNT ZNF319 ZNF853 HOXD9 PRDM15 MED12 MEF2D	1.05e-07	1271	35	13	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SREBF2 FOXJ2 NCOA3 ZNF384 JUN POU6F2 BATF3 ARNT ZNF319 ZNF853 HOXD9 PRDM15 MEF2D	3.54e-07	1412	35	13	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	NCOA3 JUN NCOA6 ARNT ARID1A CREBBP MED12 MEF2D	4.86e-07	417	35	8	GO:0061629
GeneOntologyMolecularFunction	chromatin binding	SREBF2 NCOA3 JUN NCOA6 ARID1A NONO PRDM15 CREBBP MED12	3.69e-06	739	35	9	GO:0003682
GeneOntologyMolecularFunction	transcription factor binding	NCOA3 JUN NCOA6 ARNT ARID1A CREBBP MED12 MEF2D ARID2	4.30e-06	753	35	9	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	NCOA3 JUN NCOA6 ARNT ARID1A CREBBP MED12 MEF2D	5.83e-06	582	35	8	GO:0140297
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA3 NCOA6 CREBBP	6.42e-06	21	35	3	GO:0042975
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA3 NCOA6 MED12	2.84e-05	34	35	3	GO:0046966
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	FOXJ2 NCOA3 ZNF384 JUN ZNF319 PRDM15 MEF2D	4.47e-05	560	35	7	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	FOXJ2 NCOA3 ZNF384 JUN ZNF319 PRDM15 MEF2D	4.78e-05	566	35	7	GO:0001216
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA3 NCOA6 MED12	1.66e-04	61	35	3	GO:0030374
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA3 NCOA6 ARID1A CREBBP MED12	1.74e-04	303	35	5	GO:0003713
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA3 NCOA6 ARID1A MED12	3.11e-04	187	35	4	GO:0016922
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA3 NCOA6 TOB1 ARID1A CREBBP MED12	3.92e-04	562	35	6	GO:0003712
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 MED12	4.49e-04	18	35	2	GO:0042809
GeneOntologyMolecularFunction	SMAD binding	JUN TOB1 CREBBP	4.57e-04	86	35	3	GO:0046332
GeneOntologyMolecularFunction	cyclin-dependent protein serine/threonine kinase activity	CCNK CDK19	1.26e-03	30	35	2	GO:0004693
GeneOntologyMolecularFunction	cyclin-dependent protein kinase activity	CCNK CDK19	1.26e-03	30	35	2	GO:0097472
GeneOntologyMolecularFunction	disordered domain specific binding	NCOA3 CREBBP	2.12e-03	39	35	2	GO:0097718
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	SREBF2 JUN BATF3 HOXD9	2.29e-03	320	35	4	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	SREBF2 JUN BATF3 HOXD9	2.45e-03	326	35	4	GO:0001217
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA3 NCOA6 TOB1 ARID1A CREBBP MED12 YTHDF3	3.52e-03	1160	35	7	GO:0030674
GeneOntologyMolecularFunction	histone acetyltransferase activity	NCOA3 CREBBP	3.61e-03	51	35	2	GO:0004402
GeneOntologyMolecularFunction	protein domain specific binding	NCOA3 ZNF384 JUN NCOA6 ATXN2 CREBBP	3.80e-03	875	35	6	GO:0019904
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA3 NCOA6	3.89e-03	53	35	2	GO:0030331
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	NCOA3 CREBBP	4.18e-03	55	35	2	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	NCOA3 CREBBP	4.96e-03	60	35	2	GO:0034212
GeneOntologyMolecularFunction	general transcription initiation factor binding	JUN CREBBP	5.62e-03	64	35	2	GO:0140296
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	NCOA3 CREBBP	5.97e-03	66	35	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	NCOA3 CREBBP	5.97e-03	66	35	2	GO:0001098
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA3 NCOA6 TOB1 ARID1A CREBBP MED12 YTHDF3	8.21e-03	1356	35	7	GO:0060090
GeneOntologyMolecularFunction	N-acetyltransferase activity	NCOA3 CREBBP	8.25e-03	78	35	2	GO:0008080
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	PAXIP1 SREBF2 FOXJ2 TET2 NCOA3 ZNF384 JUN NCOA6 ARNT ZNF319 HOXD9 PRDM15 CREBBP FUBP3 CCNK MED12 MEF2D ARID2	1.11e-12	1390	35	18	GO:0045944
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	PAXIP1 TET2 JUN NCOA6 ARID1A MED12	2.29e-06	231	35	6	GO:0006352
GeneOntologyBiologicalProcess	embryonic organ development	NCOA3 NCOA6 ARNT ARID1A HOXD9 MED12 ARID2	3.68e-05	561	35	7	GO:0048568
GeneOntologyBiologicalProcess	positive regulation of gene expression	PAXIP1 TET2 NCOA3 SEC16B ARNT TOB1 ARID1A CREBBP FUBP3 YTHDF3	1.01e-04	1446	35	10	GO:0010628
GeneOntologyBiologicalProcess	positive regulation of vascular associated smooth muscle cell proliferation	FOXJ2 JUN MEF2D	1.58e-04	62	35	3	GO:1904707
GeneOntologyBiologicalProcess	animal organ morphogenesis	TET2 NCOA3 JUN ARID1A HOXD9 MED12 MEF2D HCN1 ARID2	2.02e-04	1269	35	9	GO:0009887
GeneOntologyBiologicalProcess	positive regulation of DNA metabolic process	PAXIP1 JUN ARID1A CREBBP ARID2	2.32e-04	333	35	5	GO:0051054
GeneOntologyBiologicalProcess	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	TNRC6B TOB1	2.51e-04	14	35	2	GO:0060213
GeneOntologyBiologicalProcess	transcription initiation at RNA polymerase II promoter	PAXIP1 TET2 ARID1A MED12	2.69e-04	186	35	4	GO:0006367
GeneOntologyBiologicalProcess	positive regulation of DNA-templated transcription initiation	PAXIP1 JUN MED12	3.00e-04	77	35	3	GO:2000144
GeneOntologyBiologicalProcess	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	TNRC6B TOB1	3.31e-04	16	35	2	GO:1900153
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA poly(A) tail shortening	TNRC6B TOB1	3.31e-04	16	35	2	GO:0060211
GeneOntologyBiologicalProcess	placenta development	NCOA3 NCOA6 ARNT ARID1A	3.35e-04	197	35	4	GO:0001890
GeneOntologyBiologicalProcess	positive regulation of DNA recombination	PAXIP1 CREBBP ARID2	3.36e-04	80	35	3	GO:0045911
GeneOntologyBiologicalProcess	regulation of stem cell division	NCOA3 PRDM15	4.21e-04	18	35	2	GO:2000035
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription initiation	PAXIP1 JUN MED12	4.91e-04	91	35	3	GO:2000142
GeneOntologyBiologicalProcess	embryo development	NCOA3 NCOA6 ARNT ARID1A HOXD9 CREBBP CCNK MED12 ARID2	5.08e-04	1437	35	9	GO:0009790
GeneOntologyBiologicalProcess	positive regulation of double-strand break repair	ARID1A CREBBP ARID2	5.57e-04	95	35	3	GO:2000781
GeneOntologyBiologicalProcess	nucleosome disassembly	ARID1A ARID2	6.33e-04	22	35	2	GO:0006337
GeneOntologyBiologicalProcess	stem cell population maintenance	NCOA3 ARID1A CREBBP MED12	6.73e-04	237	35	4	GO:0019827
GeneOntologyBiologicalProcess	chordate embryonic development	NCOA3 NCOA6 ARNT ARID1A HOXD9 CCNK MED12	7.05e-04	906	35	7	GO:0043009
GeneOntologyBiologicalProcess	maintenance of cell number	NCOA3 ARID1A CREBBP MED12	7.27e-04	242	35	4	GO:0098727
GeneOntologyBiologicalProcess	protein-DNA complex disassembly	ARID1A ARID2	7.54e-04	24	35	2	GO:0032986
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	NCOA3 NCOA6 ARNT ARID1A HOXD9 CCNK MED12	8.17e-04	929	35	7	GO:0009792
GeneOntologyBiologicalProcess	regulation of vascular associated smooth muscle cell proliferation	FOXJ2 JUN MEF2D	8.99e-04	112	35	3	GO:1904705
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	TNRC6B TOB1	9.56e-04	27	35	2	GO:1900151
GeneOntologyBiologicalProcess	DNA damage response	PAXIP1 NCOA6 ARID1A NONO CREBBP CCNK ARID2	9.85e-04	959	35	7	GO:0006974
GeneOntologyBiologicalProcess	vascular associated smooth muscle cell proliferation	FOXJ2 JUN MEF2D	1.02e-03	117	35	3	GO:1990874
GeneOntologyBiologicalProcess	embryonic placenta development	NCOA3 NCOA6 ARNT	1.07e-03	119	35	3	GO:0001892
GeneOntologyBiologicalProcess	regulation of nucleotide-excision repair	ARID1A ARID2	1.10e-03	29	35	2	GO:2000819
GeneOntologyCellularComponent	nuclear protein-containing complex	PAXIP1 NCOA3 JUN NCOA6 BATF3 ARNT ARID1A NONO CREBBP CCNK MED12 ARID2 CDK19	1.04e-07	1377	34	13	GO:0140513
GeneOntologyCellularComponent	chromatin	SREBF2 FOXJ2 NCOA3 JUN POU6F2 BATF3 ARNT ARID1A HOXD9 CREBBP MEF2D ARID2	1.92e-06	1480	34	12	GO:0000785
GeneOntologyCellularComponent	nuclear cyclin-dependent protein kinase holoenzyme complex	CCNK MED12 CDK19	3.15e-06	18	34	3	GO:0019908
GeneOntologyCellularComponent	transcription regulator complex	NCOA3 JUN NCOA6 BATF3 ARNT NONO CREBBP ARID2	3.93e-06	596	34	8	GO:0005667
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NCOA3 JUN BATF3 ARNT NONO CREBBP	4.55e-06	272	34	6	GO:0090575
GeneOntologyCellularComponent	CKM complex	MED12 CDK19	2.56e-05	5	34	2	GO:1990508
GeneOntologyCellularComponent	cyclin-dependent protein kinase holoenzyme complex	CCNK MED12 CDK19	1.33e-04	61	34	3	GO:0000307
GeneOntologyCellularComponent	MLL3/4 complex	PAXIP1 NCOA6	1.68e-04	12	34	2	GO:0044666
GeneOntologyCellularComponent	SWI/SNF complex	ARID1A ARID2	1.09e-03	30	34	2	GO:0016514
GeneOntologyCellularComponent	nuclear matrix	PAXIP1 NONO ARID2	1.51e-03	140	34	3	GO:0016363
GeneOntologyCellularComponent	serine/threonine protein kinase complex	CCNK MED12 CDK19	2.10e-03	157	34	3	GO:1902554
GeneOntologyCellularComponent	protein kinase complex	CCNK MED12 CDK19	2.63e-03	170	34	3	GO:1902911
GeneOntologyCellularComponent	nuclear periphery	PAXIP1 NONO ARID2	2.67e-03	171	34	3	GO:0034399
GeneOntologyCellularComponent	transferase complex	PAXIP1 NCOA6 CREBBP CCNK MED12 CDK19	4.18e-03	963	34	6	GO:1990234
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	SREBF2 SEC16B	4.86e-03	64	34	2	GO:0012507
GeneOntologyCellularComponent	dendritic shaft	FUBP3 HCN1	6.45e-03	74	34	2	GO:0043198
GeneOntologyCellularComponent	histone methyltransferase complex	PAXIP1 NCOA6	6.62e-03	75	34	2	GO:0035097
HumanPheno	Downslanted palpebral fissures	KCNN3 TNRC6B PACS1 NONO CREBBP HS6ST2 MED12 HCN1 ARID2 CDK19	1.37e-07	497	15	10	HP:0000494
HumanPheno	Thin vermilion border	TNRC6B PACS1 ARID1A NONO CREBBP CCNK HS6ST2 MED12 ARID2	6.73e-07	433	15	9	HP:0000233
HumanPheno	Abnormality of the frontal hairline	KCNN3 PACS1 ARID1A CREBBP CCNK MED12 ARID2	1.04e-06	215	15	7	HP:0000599
HumanPheno	Abnormality of upper lip vermillion	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 ARID2 CDK19	1.22e-06	464	15	9	HP:0011339
HumanPheno	Macrostomia	KCNN3 PACS1 ARID1A NONO MED12 ARID2 CDK19	1.22e-06	220	15	7	HP:0000181
HumanPheno	Wide mouth	KCNN3 PACS1 ARID1A NONO MED12 ARID2 CDK19	1.22e-06	220	15	7	HP:0000154
HumanPheno	Thin upper lip vermilion	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 ARID2	1.51e-06	339	15	8	HP:0000219
HumanPheno	Thin lips	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 ARID2	1.51e-06	339	15	8	HP:0000213
HumanPheno	Autistic behavior	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	2.62e-06	678	15	10	HP:0000729
HumanPheno	Abnormality of the palpebral fissures	KCNN3 TNRC6B PACS1 NONO CREBBP CCNK HS6ST2 MED12 HCN1 ARID2 CDK19	2.68e-06	880	15	11	HP:0008050
HumanPheno	Thick nasal alae	ARID1A CCNK MED12 ARID2	3.77e-06	39	15	4	HP:0009928
HumanPheno	Language impairment	TNRC6B PACS1 ARID1A ATXN2 NONO CREBBP CCNK HS6ST2 MED12 HCN1 ARID2 CDK19	5.00e-06	1178	15	12	HP:0002463
HumanPheno	Slanting of the palpebral fissure	KCNN3 TNRC6B PACS1 NONO CREBBP HS6ST2 MED12 HCN1 ARID2 CDK19	5.86e-06	739	15	10	HP:0200006
HumanPheno	Diagnostic behavioral phenotype	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	6.48e-06	747	15	10	HP:0025783
HumanPheno	Abnormality of mouth size	KCNN3 PACS1 ARID1A NONO CREBBP MED12 ARID2 CDK19	8.38e-06	425	15	8	HP:0011337
HumanPheno	Abnormality of the hairline	KCNN3 PACS1 ARID1A CREBBP CCNK MED12 ARID2	8.56e-06	294	15	7	HP:0009553
HumanPheno	Oral aversion	PACS1 ARID1A ARID2	1.37e-05	17	15	3	HP:0012523
HumanPheno	Recurrent maladaptive behavior	TET2 TNRC6B PACS1 ARID1A ATXN2 NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	1.42e-05	1293	15	12	HP:5200241
HumanPheno	Congenital abnormal hair pattern	KCNN3 PACS1 ARID1A CREBBP CCNK MED12 ARID2	1.73e-05	327	15	7	HP:0011361
HumanPheno	Unsteady gait	PACS1 ARID1A ATXN2 CREBBP HCN1 ARID2 CDK19	3.08e-05	357	15	7	HP:0002317
HumanPheno	Delayed speech and language development	TNRC6B PACS1 ARID1A NONO CREBBP CCNK HS6ST2 MED12 HCN1 ARID2 CDK19	3.22e-05	1123	15	11	HP:0000750
HumanPheno	Aggressive behavior	PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	3.55e-05	516	15	8	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	3.55e-05	516	15	8	HP:0006919
HumanPheno	Pes planus	KCNN3 PACS1 NONO CREBBP CCNK MED12 HCN1	3.56e-05	365	15	7	HP:0001763
HumanPheno	Abnormal eyelid morphology	KCNN3 TNRC6B PACS1 ARID1A NONO CREBBP CCNK HS6ST2 MED12 HCN1 ARID2 CDK19	3.64e-05	1408	15	12	HP:0000492
HumanPheno	Abnormal social development	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	3.90e-05	908	15	10	HP:0025732
HumanPheno	Perseverative thought	NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	4.40e-05	377	15	7	HP:0030223
HumanPheno	Low anterior hairline	KCNN3 PACS1 ARID1A CREBBP ARID2	4.45e-05	147	15	5	HP:0000294
HumanPheno	Patent ductus arteriosus	KCNN3 PACS1 ARID1A NONO CREBBP MED12 ARID2	4.79e-05	382	15	7	HP:0001643
HumanPheno	Disordered formal thought process	NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	5.13e-05	386	15	7	HP:0025769
HumanPheno	Abnormal nasal tip morphology	KCNN3 PACS1 ARID1A CCNK MED12 ARID2 CDK19	5.13e-05	386	15	7	HP:0000436
HumanPheno	Abnormality of the forehead	KCNN3 PACS1 ARID1A NONO CREBBP CCNK HS6ST2 MED12 HCN1 ARID2 CDK19	6.67e-05	1208	15	11	HP:0000290
HumanPheno	Abnormal thought pattern	NONO CREBBP CCNK MED12 HCN1 ARID2 CDK19	6.89e-05	404	15	7	HP:5200269
HumanPheno	Clinodactyly	KCNN3 PACS1 ARID1A NONO CREBBP CCNK MED12 ARID2	7.75e-05	574	15	8	HP:0030084
HumanPheno	Abnormal lip morphology	KCNN3 TNRC6B PACS1 ARID1A NONO CREBBP CCNK HS6ST2 MED12 ARID2 CDK19	9.28e-05	1249	15	11	HP:0000159
HumanPheno	Abnormality of the scalp hair	KCNN3 PACS1 ARID1A CREBBP CCNK MED12 ARID2	1.08e-04	433	15	7	HP:0100037
HumanPheno	Disinhibition	TNRC6B PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	1.22e-04	807	15	9	HP:0000734
HumanPheno	Inappropriate behavior	TNRC6B PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	1.22e-04	807	15	9	HP:0000719
HumanPheno	Abnormal response to social norms	TNRC6B PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	1.22e-04	807	15	9	HP:5200123
HumanPheno	Social disinhibition	TNRC6B PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	1.22e-04	807	15	9	HP:5200029
HumanPheno	Reduced impulse control	TET2 TNRC6B PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	1.24e-04	1032	15	10	HP:5200045
HumanPheno	Abnormal scalp morphology	KCNN3 PACS1 ARID1A CREBBP CCNK MED12 ARID2	1.38e-04	450	15	7	HP:0001965
HumanPheno	Deviated nasal septum	NONO CREBBP	1.69e-04	7	15	2	HP:0004411
HumanPheno	Abnormality of thumb phalanx	KCNN3 PACS1 NONO CREBBP MED12	2.17e-04	205	15	5	HP:0009602
HumanPheno	Abnormally increased volition	TNRC6B PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	2.21e-04	869	15	9	HP:5200263
HumanPheno	Long thumb	KCNN3 MED12	2.24e-04	8	15	2	HP:0032524
HumanPheno	Prominent nose	NONO CREBBP MED12 CDK19	2.34e-04	110	15	4	HP:0000448
HumanPheno	Generalized hypotonia	KCNN3 PACS1 ATXN2 NONO MED12 HCN1 ARID2 CDK19	2.38e-04	671	15	8	HP:0001290
HumanPheno	Abnormal eyebrow morphology	KCNN3 PACS1 ARID1A CREBBP CCNK MED12 ARID2 CDK19	2.46e-04	674	15	8	HP:0000534
HumanPheno	Triangular shaped phalanges of the hand	KCNN3 PACS1 NONO CREBBP MED12	2.66e-04	214	15	5	HP:0009774
HumanPheno	Infantile muscular hypotonia	KCNN3 PACS1 ARID1A MED12 ARID2	2.96e-04	219	15	5	HP:0008947
HumanPheno	Impairment in personality functioning	TNRC6B PACS1 ARID1A ATXN2 NONO CREBBP MED12 HCN1 ARID2 CDK19	3.01e-04	1141	15	10	HP:0031466
HumanPheno	Gastroesophageal reflux	PACS1 NONO CREBBP MED12 HCN1 ARID2 CDK19	3.31e-04	517	15	7	HP:0002020
HumanPheno	Congenital malformation of the great arteries	KCNN3 PACS1 ARID1A NONO CREBBP MED12 ARID2	3.83e-04	529	15	7	HP:0011603
HumanPheno	Restricted or repetitive behaviors or interests	CREBBP CCNK MED12 HCN1 ARID2 CDK19	3.90e-04	368	15	6	HP:0031432
HumanPheno	Long eyelashes	KCNN3 PACS1 ARID1A CREBBP	4.31e-04	129	15	4	HP:0000527
HumanPheno	Narrow nasal bridge	NONO CREBBP MED12	4.43e-04	53	15	3	HP:0000446
HumanPheno	Hypoplastic fingernail	KCNN3 ARID1A ARID2	4.43e-04	53	15	3	HP:0001804
HumanPheno	Abnormal stomach morphology	TET2 PACS1 NONO CREBBP MED12 HCN1 ARID2 CDK19	4.86e-04	742	15	8	HP:0002577
HumanPheno	Patent foramen ovale	PACS1 NONO CREBBP MED12	5.13e-04	135	15	4	HP:0001655
HumanPheno	Joint hypermobility	KCNN3 TNRC6B ARID1A NONO CREBBP MED12 ARID2	5.27e-04	557	15	7	HP:0001382
HumanPheno	Thick lower lip vermilion	KCNN3 ARID1A MED12 ARID2	5.28e-04	136	15	4	HP:0000179
HumanPheno	Hyperactivity	TNRC6B ARID1A CREBBP MED12 HCN1 ARID2 CDK19	5.33e-04	558	15	7	HP:0000752
HumanPheno	Abnormal upper lip morphology	TNRC6B PACS1 ARID1A NONO CREBBP CCNK MED12 ARID2 CDK19	5.69e-04	980	15	9	HP:0000177
HumanPheno	Short philtrum	ARID1A NONO CREBBP MED12 ARID2	5.78e-04	253	15	5	HP:0000322
HumanPheno	Neoplasm of the liver	POU6F2 ARID1A CREBBP ARID2	5.89e-04	140	15	4	HP:0002896
HumanPheno	Abnormality of the palmar creases	KCNN3 PACS1 CREBBP MED12 CDK19	6.56e-04	260	15	5	HP:0010490
HumanPheno	Cryptorchidism	TNRC6B PACS1 POU6F2 ARID1A NONO CREBBP MED12 ARID2	6.88e-04	780	15	8	HP:0000028
HumanPheno	Autism	NONO CREBBP MED12 HCN1 CDK19	7.04e-04	264	15	5	HP:0000717
HumanPheno	Abnormal palmar dermatoglyphics	KCNN3 PACS1 CREBBP MED12 CDK19	7.16e-04	265	15	5	HP:0001018
HumanPheno	Hypoplastic fifth fingernail	ARID1A ARID2	7.22e-04	14	15	2	HP:0008398
HumanPheno	Abnormal motivation	TNRC6B PACS1 ARID1A ATXN2 NONO CREBBP MED12 HCN1 ARID2 CDK19	7.27e-04	1263	15	10	HP:5200275
HumanPheno	Abnormal volitional state	TNRC6B PACS1 ARID1A ATXN2 NONO CREBBP MED12 HCN1 ARID2 CDK19	7.27e-04	1263	15	10	HP:0025780
HumanPheno	Impulsivity	NONO CREBBP HCN1 CDK19	7.46e-04	149	15	4	HP:0100710
HumanPheno	Tooth malposition	KCNN3 PACS1 NONO CREBBP MED12 CDK19	7.77e-04	418	15	6	HP:0000692
HumanPheno	Abnormality of the dentition	KCNN3 PACS1 ARID1A NONO CREBBP MED12 HCN1 ARID2 CDK19	8.37e-04	1030	15	9	HP:0000164
HumanPheno	Thick eyebrow	KCNN3 ARID1A CREBBP ARID2	8.45e-04	154	15	4	HP:0000574
HumanPheno	Prominent lips	KCNN3 ARID1A MED12 ARID2	8.87e-04	156	15	4	HP:0000184
HumanPheno	Brachydactyly (hand)	KCNN3 PACS1 ARID1A CREBBP MED12 ARID2	9.04e-04	430	15	6	HP:0100667
HumanPheno	Thick vermilion border	KCNN3 ARID1A NONO MED12 ARID2	9.06e-04	279	15	5	HP:0012471
HumanPheno	Compulsive behaviors	CREBBP MED12 HCN1 ARID2	9.31e-04	158	15	4	HP:0000722
HumanPheno	Broad nasal tip	KCNN3 ARID1A CCNK ARID2	9.53e-04	159	15	4	HP:0000455
HumanPheno	Absent speech	PACS1 ARID1A CREBBP MED12 HCN1 ARID2	9.73e-04	436	15	6	HP:0001344
HumanPheno	Abnormal eyelash morphology	KCNN3 PACS1 ARID1A CREBBP ARID2	9.83e-04	284	15	5	HP:0000499
HumanPheno	Prominent eyelashes	ARID1A ARID2	1.07e-03	17	15	2	HP:0011231
HumanPheno	Myopia	PACS1 ARID1A NONO CREBBP HS6ST2 ARID2	1.11e-03	447	15	6	HP:0000545
HumanPheno	Triangular face	TNRC6B NONO HS6ST2 MED12	1.15e-03	167	15	4	HP:0000325
HumanPheno	Deep philtrum	CREBBP MED12 ARID2	1.23e-03	75	15	3	HP:0002002
HumanPheno	Intellectual disability, moderate	ARID1A CCNK MED12 ARID2	1.28e-03	172	15	4	HP:0002342
HumanPheno	Abnormal distal phalanx morphology of finger	KCNN3 ARID1A NONO CREBBP	1.34e-03	174	15	4	HP:0009832
HumanPheno	Deficiency of speech development	PACS1 ARID1A CREBBP MED12 HCN1 ARID2	1.34e-03	463	15	6	HP:0002116
HumanPheno	Hypoplastic fifth toenail	ARID1A ARID2	1.34e-03	19	15	2	HP:0011937
HumanPheno	Absent toenail	KCNN3 ARID1A	1.34e-03	19	15	2	HP:0001802
HumanPheno	Short phalanx of finger	KCNN3 PACS1 ARID1A CREBBP MED12	1.38e-03	306	15	5	HP:0009803
HumanPheno	Hypersplenism	TET2 MED12	1.49e-03	20	15	2	HP:0001971
HumanPheno	Abnormal spleen physiology	TET2 MED12	1.49e-03	20	15	2	HP:0025409
HumanPheno	Inguinal hernia	TNRC6B PACS1 ARID1A CREBBP MED12	1.50e-03	312	15	5	HP:0000023
HumanPheno	Abnormal dermatoglyphics	KCNN3 PACS1 CREBBP MED12 CDK19	1.55e-03	314	15	5	HP:0007477
HumanPheno	Aplastic/hypoplastic fingernail	KCNN3 ARID1A ARID2	1.59e-03	82	15	3	HP:0008384
HumanPheno	Talipes valgus	NONO HCN1	1.65e-03	21	15	2	HP:0004684
MousePheno	increased liver glycogen level	NCOA3 ATXN2 CREBBP	5.10e-05	34	30	3	MP:0010400
MousePheno	embryonic lethality during organogenesis, complete penetrance	PAXIP1 JUN NCOA6 ARNT ARID1A CREBBP MED12 ARID2	8.32e-05	700	30	8	MP:0011098
MousePheno	abnormal hematopoietic stem cell morphology	TET2 ARID1A CREBBP CDK19	9.11e-05	112	30	4	MP:0004808
MousePheno	increased hematopoietic stem cell number	TET2 ARID1A CDK19	1.04e-04	43	30	3	MP:0004809
MousePheno	absent organized vascular network	PAXIP1 CREBBP	1.24e-04	8	30	2	MP:0000263
MousePheno	thin myocardium compact layer	NCOA6 CREBBP ARID2	1.27e-04	46	30	3	MP:0004057
MousePheno	abnormal visceral yolk sac morphology	PAXIP1 ARNT ARID1A PRDM15 CREBBP	1.33e-04	236	30	5	MP:0001718
MousePheno	abnormal cardiovascular development	PAXIP1 JUN NCOA6 ARNT ARID1A CREBBP MED12 ARID2	2.14e-04	802	30	8	MP:0002925
MousePheno	increased glycogen level	NCOA3 ATXN2 CREBBP	2.41e-04	57	30	3	MP:0005440
MousePheno	abnormal myocardium compact layer morphology	NCOA6 CREBBP ARID2	3.89e-04	67	30	3	MP:0004056
MousePheno	embryonic lethality during organogenesis	PAXIP1 JUN NCOA6 ARNT ARID1A CREBBP MED12 ARID2	3.91e-04	876	30	8	MP:0006207
MousePheno	decreased embryo size	PAXIP1 NCOA3 NCOA6 ARNT ARID1A PRDM15 CREBBP	3.94e-04	659	30	7	MP:0001698
MousePheno	abnormal hematopoietic precursor cell morphology	TET2 NCOA6 ARID1A CREBBP CDK19	3.98e-04	299	30	5	MP:0013707
MousePheno	abnormal spongiotrophoblast layer morphology	NCOA6 ARNT ARID1A	4.81e-04	72	30	3	MP:0004255
MousePheno	abnormal placenta junctional zone morphology	NCOA6 ARNT ARID1A	6.56e-04	80	30	3	MP:0008957
MousePheno	decreased fetal cardiomyocyte proliferation	NCOA6 ARID2	6.67e-04	18	30	2	MP:0011395
MousePheno	abnormal liver glycogen level	NCOA3 ATXN2 CREBBP	6.80e-04	81	30	3	MP:0012777
Domain	Nuc_rcpt_coact	NCOA3 CREBBP	5.09e-05	6	35	2	IPR009110
Domain	-	ARID1A ARID2	3.53e-04	15	35	2	1.10.150.60
Domain	ARID	ARID1A ARID2	3.53e-04	15	35	2	PF01388
Domain	BRIGHT	ARID1A ARID2	3.53e-04	15	35	2	SM00501
Domain	ARID_dom	ARID1A ARID2	3.53e-04	15	35	2	IPR001606
Domain	ARID	ARID1A ARID2	3.53e-04	15	35	2	PS51011
Domain	PAS	NCOA3 ARNT	9.96e-04	25	35	2	PF00989
Domain	PAS_fold	NCOA3 ARNT	9.96e-04	25	35	2	IPR013767
Domain	-	SREBF2 NCOA3 ARNT	1.10e-03	109	35	3	4.10.280.10
Domain	HLH	SREBF2 NCOA3 ARNT	1.16e-03	111	35	3	PF00010
Domain	HLH	SREBF2 NCOA3 ARNT	1.32e-03	116	35	3	SM00353
Domain	BHLH	SREBF2 NCOA3 ARNT	1.35e-03	117	35	3	PS50888
Domain	bHLH_dom	SREBF2 NCOA3 ARNT	1.39e-03	118	35	3	IPR011598
Domain	PAS	NCOA3 ARNT	1.63e-03	32	35	2	SM00091
Domain	PAS	NCOA3 ARNT	1.84e-03	34	35	2	IPR000014
Domain	bZIP_1	JUN BATF3	1.84e-03	34	35	2	PF00170
Domain	PAS	NCOA3 ARNT	1.84e-03	34	35	2	PS50112
Domain	BRLZ	JUN BATF3	4.27e-03	52	35	2	SM00338
Domain	BZIP	JUN BATF3	4.43e-03	53	35	2	PS50217
Domain	BZIP_BASIC	JUN BATF3	4.43e-03	53	35	2	PS00036
Domain	bZIP	JUN BATF3	4.59e-03	54	35	2	IPR004827
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	SREBF2 NCOA3 NCOA6 ARNT CREBBP MED12 CDK19	1.02e-09	118	25	7	M27316
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	SREBF2 NCOA3 NCOA6 CREBBP MED12 CDK19	6.04e-09	84	25	6	M1008
Pathway	REACTOME_ADIPOGENESIS	SREBF2 NCOA3 NCOA6 CREBBP MED12 CDK19	3.09e-08	110	25	6	M48259
Pathway	PID_HNF3A_PATHWAY	NCOA3 JUN PRDM15 CREBBP	9.95e-07	44	25	4	M285
Pathway	REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	PAXIP1 NCOA3 JUN NCOA6 CREBBP	2.07e-06	122	25	5	M29689
Pathway	BIOCARTA_VDR_PATHWAY	NCOA3 ARID1A CREBBP	7.42e-06	22	25	3	MM1370
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	PAXIP1 SREBF2 TNRC6B NCOA3 JUN NCOA6 ARID1A CREBBP MED12 MEF2D CDK19	1.32e-05	1432	25	11	M509
Pathway	WP_KLEEFSTRA_SYNDROME	PAXIP1 NCOA6 ARID1A	1.75e-05	29	25	3	M48076
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	TNRC6B ARNT CREBBP	2.84e-05	34	25	3	M46422
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	SREBF2 NCOA6 CREBBP	5.40e-05	42	25	3	M27172
Pathway	REACTOME_HEME_SIGNALING	NCOA6 CREBBP MEF2D	8.60e-05	49	25	3	M41832
Pathway	BIOCARTA_PCAF_PATHWAY	JUN CREBBP	1.08e-04	9	25	2	MM1533
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA6 CREBBP MEF2D	1.22e-04	55	25	3	M27145
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	SREBF2 NCOA6 CREBBP	1.22e-04	55	25	3	M27001
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	TNRC6B NCOA3 JUN CREBBP	1.28e-04	149	25	4	M27888
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	ARNT CREBBP	1.64e-04	11	25	2	M26924
Pathway	WP_EGFEGFR_SIGNALING	NCOA3 JUN ATXN2 MEF2D	1.76e-04	162	25	4	M39334
Pathway	PID_ERA_GENOMIC_PATHWAY	NCOA3 JUN PRDM15	1.91e-04	64	25	3	M200
Pathway	PID_HIF1_TFPATHWAY	JUN ARNT CREBBP	2.09e-04	66	25	3	M255
Pathway	BIOCARTA_PCAF_PATHWAY	JUN CREBBP	2.33e-04	13	25	2	M22007
Pathway	KEGG_RENAL_CELL_CARCINOMA	JUN ARNT CREBBP	2.49e-04	70	25	3	M13266
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA6 CREBBP MEF2D	2.49e-04	70	25	3	M938
Pathway	REACTOME_METABOLISM_OF_LIPIDS	SREBF2 NCOA3 NCOA6 ARNT CREBBP MED12 CDK19	2.57e-04	757	25	7	M27451
Pathway	BIOCARTA_HIF_PATHWAY	JUN ARNT	3.13e-04	15	25	2	M13324
Pathway	WP_RUBINSTEINTAYBI_SYNDROME_1	NCOA3 CREBBP	3.13e-04	15	25	2	M48323
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA6 CREBBP	4.54e-04	18	25	2	M26942
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	NCOA3 JUN CREBBP	5.40e-04	91	25	3	M39700
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	TNRC6B NCOA3 JUN CREBBP	5.64e-04	220	25	4	M27794
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	TNRC6B NCOA3 JUN	5.75e-04	93	25	3	M27572
Pathway	REACTOME_MITOCHONDRIAL_BIOGENESIS	NCOA6 CREBBP MEF2D	6.31e-04	96	25	3	M26973
Pathway	REACTOME_RSV_HOST_INTERACTIONS	CREBBP MED12 CDK19	6.71e-04	98	25	3	M48247
Pathway	REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES	ARNT CREBBP	6.82e-04	22	25	2	M46437
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	TNRC6B ARID1A CREBBP ARID2	7.46e-04	237	25	4	M27786
Pathway	WP_ANGIOGENESIS	ARNT CREBBP	8.14e-04	24	25	2	M39556
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP	8.14e-04	24	25	2	M13404
Pathway	PID_HDAC_CLASSIII_PATHWAY	CREBBP MEF2D	9.56e-04	26	25	2	M32
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	PAXIP1 TET2 NCOA6 ARID1A	9.66e-04	254	25	4	M27131
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA6 CREBBP	1.03e-03	27	25	2	M26943
Pathway	PID_TCR_CALCIUM_PATHWAY	JUN BATF3	1.11e-03	28	25	2	M235
Pathway	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	TNRC6B JUN CREBBP	1.18e-03	119	25	3	M607
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY	CREBBP MED12 CDK19	1.21e-03	120	25	3	M48233
Pathway	PID_RETINOIC_ACID_PATHWAY	NCOA3 CREBBP	1.27e-03	30	25	2	M207
Pathway	PID_IL12_STAT4_PATHWAY	JUN CREBBP	1.45e-03	32	25	2	M290
Pathway	WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA	ARNT CREBBP	1.64e-03	34	25	2	M39771
Pathway	PID_HIF2PATHWAY	ARNT CREBBP	1.64e-03	34	25	2	M44
Pathway	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	TNRC6B NCOA3 JUN CREBBP	1.70e-03	296	25	4	M27869
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	TNRC6B ARID1A CREBBP	1.77e-03	137	25	3	M48232
Pathway	PID_P53_DOWNSTREAM_PATHWAY	JUN CREBBP CCNK	1.77e-03	137	25	3	M145
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1A ARID2	1.94e-03	37	25	2	M27797
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	TNRC6B JUN ARNT ARID1A CREBBP CCNK MED12 ARID2	2.02e-03	1387	25	8	M734
Pathway	WP_NUCLEAR_RECEPTORS_METAPATHWAY	NCOA3 JUN NCOA6 ARNT	2.11e-03	314	25	4	M39428
Pathway	REACTOME_METABOLISM_OF_STEROIDS	SREBF2 NCOA6 CREBBP	2.46e-03	154	25	3	M27832
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	PAXIP1 NCOA6	2.49e-03	42	25	2	M48018
Pathway	REACTOME_CELLULAR_RESPONSES_TO_STIMULI	TNRC6B JUN NCOA6 ARNT CREBBP MEF2D	2.72e-03	828	25	6	M27827
Pathway	WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873	JUN ARNT	2.85e-03	45	25	2	M39615
Pathway	PID_NFAT_TFPATHWAY	JUN BATF3	2.85e-03	45	25	2	M60
Pathway	PID_PS1_PATHWAY	JUN CREBBP	2.98e-03	46	25	2	M70
Pathway	PID_HES_HEY_PATHWAY	ARNT CREBBP	3.24e-03	48	25	2	M288
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53	TNRC6B JUN CREBBP CCNK	3.46e-03	360	25	4	M27267
Pathway	WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY	JUN ARNT	3.51e-03	50	25	2	M48087
Pathway	BIOCARTA_PPARA_PATHWAY	JUN CREBBP	3.79e-03	52	25	2	M2404
Pathway	PID_NFAT_3PATHWAY	CREBBP MEF2D	3.94e-03	53	25	2	M113
Pathway	PID_AR_TF_PATHWAY	JUN CREBBP	3.94e-03	53	25	2	M151
Pathway	WP_TGFBETA_SIGNALING_PATHWAY	JUN CREBBP	3.94e-03	53	25	2	MM15880
Pathway	WP_TGFBETA_RECEPTOR_SIGNALING	JUN CREBBP	4.23e-03	55	25	2	M39351
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PAXIP1 TET2 NCOA3 ZNF384 JUN NCOA6 ARNT ARID1A ATXN2 NONO CREBBP FUBP3 CCNK MED12 MEF2D ARID2	2.17e-15	1103	35	16	34189442
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	PAXIP1 TET2 NCOA3 JUN NCOA6 ARID1A CREBBP CCNK MED12 MEF2D	9.67e-14	268	35	10	33640491
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TNRC6B NCOA3 NCOA6 ARNT ARID1A ATXN2 NONO CREBBP FUBP3 MEF2D YTHDF3	5.62e-13	457	35	11	32344865
Pubmed	Interaction network of human early embryonic transcription factors.	PAXIP1 TET2 NCOA3 NCOA6 ARNT ARID1A CREBBP MED12 ARID2 YTHDF3	1.42e-12	351	35	10	38297188
Pubmed	Human transcription factor protein interaction networks.	PAXIP1 TET2 TNRC6B NCOA3 JUN NCOA6 ARNT ZNF319 ARID1A ATXN2 CREBBP FUBP3 MEF2D ARID2 YTHDF3	2.24e-12	1429	35	15	35140242
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	PAXIP1 NCOA3 ZNF384 ATXN2 MED12	2.54e-11	23	35	5	9225980
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	TNRC6B JUN NCOA6 ARID1A FUBP3 CCNK MED12 MEF2D ARID2 YTHDF3	2.61e-11	472	35	10	38943005
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TET2 TNRC6B NCOA3 JUN ARNT CREBBP CCNK	1.61e-10	152	35	7	38360978
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SREBF2 FOXJ2 NCOA3 ZNF384 JUN POU6F2 BATF3 ARNT HOXD9 CREBBP FUBP3	5.91e-10	877	35	11	20211142
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF384 JUN NCOA6 ARID1A ATXN2 NONO FUBP3 CCNK MEF2D ARID2 YTHDF3	1.43e-09	954	35	11	36373674
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA3 ARNT ARID1A NONO FUBP3 MED12 ARID2	2.13e-09	220	35	7	35785414
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA3 JUN NCOA6 CREBBP	4.11e-09	20	35	4	11877444
Pubmed	A census of human transcription factors: function, expression and evolution.	SREBF2 FOXJ2 NCOA3 ZNF384 JUN POU6F2 BATF3 ARNT HOXD9 MEF2D	1.42e-08	908	35	10	19274049
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA3 ZNF384 JUN NCOA6 ARID1A	2.10e-08	83	35	5	28794006
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TNRC6B NCOA6 ARID1A NONO CREBBP CCNK MED12 ARID2	5.93e-08	549	35	8	38280479
Pubmed	The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.	NCOA3 NCOA6 HOXD9 MED12	1.03e-07	43	35	4	26487511
Pubmed	Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.	NCOA3 ARID1A CREBBP	1.53e-07	11	35	3	18003620
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	PAXIP1 ARID1A NONO FUBP3 CCNK MED12	3.66e-07	283	35	6	28533407
Pubmed	A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.	JUN NCOA6 CREBBP	4.21e-07	15	35	3	10567404
Pubmed	An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.	SREBF2 CREBBP MED12	8.95e-07	19	35	3	16799563
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	ZNF384 JUN ARID1A PRDM15 CREBBP	9.51e-07	178	35	5	27637333
Pubmed	[Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].	ZNF384 MEF2D	9.84e-07	2	35	2	37544723
Pubmed	Quantifying Protection in Disordered Proteins Using Millisecond Hydrogen Exchange-Mass Spectrometry and Peptic Reference Peptides.	NCOA3 CREBBP	9.84e-07	2	35	2	28675294
Pubmed	Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin.	NCOA3 CREBBP	9.84e-07	2	35	2	21632823
Pubmed	Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.	NCOA3 NCOA6	9.84e-07	2	35	2	8758910
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	SREBF2 FOXJ2 ZNF384 JUN BATF3 HOXD9 MEF2D	1.01e-06	544	35	7	28473536
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	FOXJ2 NCOA3 JUN ARNT ARID1A PRR3 MEF2D ARID2	1.11e-06	808	35	8	20412781
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA3 NCOA6 CREBBP	1.23e-06	21	35	3	19596656
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXJ2 JUN BATF3 ARNT PRDM15 CREBBP FUBP3 MEF2D	1.72e-06	857	35	8	25609649
Pubmed	Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.	TNRC6B NONO FUBP3 YTHDF3	2.06e-06	90	35	4	33087562
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PAXIP1 TET2 NCOA3 ARID1A CREBBP ARID2	2.65e-06	398	35	6	35016035
Pubmed	Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock.	NCOA6 CREBBP	2.95e-06	3	35	2	14960326
Pubmed	Mediator modulates Gli3-dependent Sonic hedgehog signaling.	CREBBP MED12	2.95e-06	3	35	2	17000779
Pubmed	Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.	ZNF384 CREBBP	2.95e-06	3	35	2	27903646
Pubmed	Correlation of transcriptional repression by p21(SNFT) with changes in DNA.NF-AT complex interactions.	JUN BATF3	2.95e-06	3	35	2	12087103
Pubmed	Involvement of aryl hydrocarbon receptor nuclear translocator in EGF-induced c-Jun/Sp1-mediated gene expression.	JUN ARNT	2.95e-06	3	35	2	20508969
Pubmed	Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.	ARID1A ARID2	2.95e-06	3	35	2	26716708
Pubmed	Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators.	NCOA3 CREBBP	2.95e-06	3	35	2	11823864
Pubmed	Heterodimer formation between CREB and JUN proteins.	JUN CREBBP	2.95e-06	3	35	2	2138276
Pubmed	Expression and prognostic values of ARID family members in breast cancer.	ARID1A ARID2	2.95e-06	3	35	2	33592583
Pubmed	Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.	ARID1A ARID2	2.95e-06	3	35	2	24382590
Pubmed	Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.	JUN CREBBP	2.95e-06	3	35	2	8028671
Pubmed	ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.	ARID1A ARID2	2.95e-06	3	35	2	34512623
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	ARID1A NONO ARID2	3.35e-06	29	35	3	19279220
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PAXIP1 JUN NCOA6 ARNT ZNF319 ARID1A HOXD9 NONO FUBP3	3.91e-06	1294	35	9	30804502
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TNRC6B ARNT NONO CREBBP MEF2D YTHDF3	4.96e-06	444	35	6	34795231
Pubmed	Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.	SREBF2 NCOA3 NCOA6 CREBBP MEF2D	5.02e-06	250	35	5	18660489
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SREBF2 FOXJ2 JUN ARNT ARID1A CREBBP MEF2D	5.81e-06	709	35	7	22988430
Pubmed	Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53.	NCOA3 CREBBP	5.90e-06	4	35	2	10551785
Pubmed	Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).	NCOA3 CREBBP	5.90e-06	4	35	2	16227615
Pubmed	Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.	NCOA3 CREBBP	5.90e-06	4	35	2	33589584
Pubmed	Mining the human complexome database identifies RBM14 as an XPO1-associated protein involved in HIV-1 Rev function.	PACS1 NONO	5.90e-06	4	35	2	25589658
Pubmed	PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.	JUN CREBBP	5.90e-06	4	35	2	16786139
Pubmed	CBP alleviates the intramolecular inhibition of ATF-2 function.	JUN CREBBP	5.90e-06	4	35	2	9786917
Pubmed	Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.	MED12 CDK19	5.90e-06	4	35	2	29440396
Pubmed	CREB binding protein is required for both short-term and long-term memory formation.	ARNT CREBBP	5.90e-06	4	35	2	20881124
Pubmed	Regulation of the BRCA1 gene by an SRC3/53BP1 complex.	NCOA3 CREBBP	5.90e-06	4	35	2	21914189
Pubmed	Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein.	JUN BATF3	5.90e-06	4	35	2	10878360
Pubmed	CBP/p300 interact with and function as transcriptional coactivators of BRCA1.	NCOA3 CREBBP	5.90e-06	4	35	2	10655477
Pubmed	Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB.	JUN CREBBP	5.90e-06	4	35	2	12437352
Pubmed	Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma.	JUN ARNT	5.90e-06	4	35	2	19203995
Pubmed	SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.	SREBF2 CREBBP	5.90e-06	4	35	2	8918891
Pubmed	A transcriptional switch mediated by cofactor methylation.	NCOA3 CREBBP	5.90e-06	4	35	2	11701890
Pubmed	Mutation of a lysine residue in a homeodomain generates dominant negative thyroid transcription factor 1.	NCOA3 CREBBP	5.90e-06	4	35	2	15449938
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	TET2 NONO FUBP3 MED12 CDK19	7.56e-06	272	35	5	31010829
Pubmed	ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2.	ATXN2 NONO FUBP3	7.69e-06	38	35	3	30629181
Pubmed	Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.	NCOA3 CREBBP	9.82e-06	5	35	2	14766010
Pubmed	Role of nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance.	NCOA3 CREBBP	9.82e-06	5	35	2	22977234
Pubmed	Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.	JUN CREBBP	9.82e-06	5	35	2	9659924
Pubmed	Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.	JUN CREBBP	9.82e-06	5	35	2	17296604
Pubmed	Recent advances in understanding chromatin remodeling by Swi/Snf complexes.	ARID1A ARID2	9.82e-06	5	35	2	12672490
Pubmed	Transcription factor-specific requirements for coactivators and their acetyltransferase functions.	NCOA3 CREBBP	9.82e-06	5	35	2	9445475
Pubmed	Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors.	JUN NCOA6	9.82e-06	5	35	2	11704680
Pubmed	Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.	NCOA6 CREBBP	9.82e-06	5	35	2	11912212
Pubmed	SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.	ARID1A ARID2	9.82e-06	5	35	2	33318036
Pubmed	p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor.	NONO CREBBP	9.82e-06	5	35	2	12810069
Pubmed	Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity.	NCOA3 CREBBP	9.82e-06	5	35	2	10224118
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA3 PACS1 SEC16B JUN NCOA6 CCNK MEF2D	1.03e-05	774	35	7	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SREBF2 TNRC6B PACS1 POU6F2 ARID1A ATXN2 PRDM15 CREBBP CDK19	1.21e-05	1489	35	9	28611215
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	SREBF2 FOXJ2 TET2 TNRC6B ARID1A ARID2	1.45e-05	536	35	6	15840001
Pubmed	Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.	NCOA6 CREBBP	1.47e-05	6	35	2	15150259
Pubmed	Temporal/spatial expression of nuclear receptor coactivators in the mouse lung.	NCOA3 CREBBP	1.47e-05	6	35	2	11076796
Pubmed	Extracellular signals regulate rapid coactivator recruitment at AP-1 sites by altered phosphorylation of both CREB binding protein and c-jun.	JUN CREBBP	1.47e-05	6	35	2	18443043
Pubmed	Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins.	NCOA3 CREBBP	1.47e-05	6	35	2	10777539
Pubmed	Role of CBP in regulating HIF-1-mediated activation of transcription.	ARNT CREBBP	1.47e-05	6	35	2	15615775
Pubmed	The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.	JUN CREBBP	1.47e-05	6	35	2	10327051
Pubmed	A genetic compensatory mechanism regulated by Jun and Mef2d modulates the expression of distinct class IIa Hdacs to ensure peripheral nerve myelination and repair.	JUN MEF2D	1.47e-05	6	35	2	35076395
Pubmed	PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic.	PACS1 JUN	1.47e-05	6	35	2	11331585
Pubmed	Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.	JUN MEF2D	1.47e-05	6	35	2	20590529
Pubmed	Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.	KCNN3 ATXN2	1.47e-05	6	35	2	8896557
Pubmed	Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation.	JUN CREBBP	1.47e-05	6	35	2	10497212
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	SREBF2 FOXJ2 TET2 TNRC6B ARID1A ARID2	1.48e-05	538	35	6	10512203
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	NCOA6 ARID1A CREBBP ARID2	1.88e-05	157	35	4	30186101
Pubmed	BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.	NCOA3 CREBBP	2.06e-05	7	35	2	16860316
Pubmed	Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.	NCOA3 JUN	2.06e-05	7	35	2	11477071
Pubmed	The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.	NCOA3 CREBBP	2.06e-05	7	35	2	9192892
Pubmed	Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor.	JUN CREBBP	2.06e-05	7	35	2	10428834
Pubmed	The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation.	NCOA3 CREBBP	2.06e-05	7	35	2	17043108
Pubmed	ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.	PAXIP1 NCOA3	2.06e-05	7	35	2	34144977
Pubmed	Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.	BATF3 CREBBP	2.06e-05	7	35	2	12101239
Interaction	KLF5 interactions	PAXIP1 TET2 NCOA3 JUN NCOA6 ARID1A CREBBP FUBP3 MEF2D ARID2 YTHDF3	1.23e-14	195	34	11	int:KLF5
Interaction	CEBPA interactions	PAXIP1 TET2 NCOA3 ZNF384 JUN NCOA6 BATF3 ARNT ARID1A ATXN2 NONO CREBBP FUBP3 CCNK MED12 MEF2D ARID2	2.14e-12	1245	34	17	int:CEBPA
Interaction	SMG7 interactions	PAXIP1 TNRC6B NCOA3 NCOA6 ARNT ARID1A ATXN2 CREBBP FUBP3 MEF2D YTHDF3	2.72e-12	319	34	11	int:SMG7
Interaction	SP7 interactions	PAXIP1 TET2 NCOA3 NCOA6 ARNT ARID1A CREBBP FUBP3 MEF2D ARID2	5.01e-11	304	34	10	int:SP7
Interaction	NUP35 interactions	TNRC6B NCOA3 NCOA6 ARNT ARID1A ATXN2 NONO CREBBP FUBP3 MEF2D YTHDF3	5.82e-11	424	34	11	int:NUP35
Interaction	ERG interactions	PAXIP1 TET2 NCOA3 JUN NCOA6 ARID1A NONO CREBBP MEF2D	8.73e-11	223	34	9	int:ERG
Interaction	SOX9 interactions	PAXIP1 NCOA3 NCOA6 ARID1A CREBBP MED12 ARID2	2.32e-10	97	34	7	int:SOX9
Interaction	AR interactions	PAXIP1 TET2 NCOA3 JUN NCOA6 ARNT ARID1A NONO CREBBP FUBP3 CCNK MED12 MEF2D ARID2	2.48e-10	992	34	14	int:AR
Interaction	HNF1B interactions	PAXIP1 TET2 NCOA3 POU6F2 ARID1A CREBBP MEF2D ARID2	7.93e-10	190	34	8	int:HNF1B
Interaction	SOX7 interactions	PAXIP1 TET2 NCOA3 ARID1A CREBBP ARID2	4.63e-09	82	34	6	int:SOX7
Interaction	EYA4 interactions	FOXJ2 TET2 TNRC6B NCOA3 JUN ARNT CREBBP CCNK	5.52e-09	243	34	8	int:EYA4
Interaction	ASF1A interactions	ZNF384 JUN NCOA6 ARNT ARID1A PRR3 MEF2D ARID2	6.68e-09	249	34	8	int:ASF1A
Interaction	CRX interactions	PAXIP1 TET2 NCOA3 ARNT ARID1A CREBBP MED12 ARID2	7.80e-09	254	34	8	int:CRX
Interaction	SOX10 interactions	PAXIP1 NCOA3 JUN POU6F2 ARID1A ARID2	9.31e-09	92	34	6	int:SOX10
Interaction	SOX17 interactions	PAXIP1 NCOA3 JUN NCOA6 ARID1A ARID2	1.13e-08	95	34	6	int:SOX17
Interaction	EGR2 interactions	PAXIP1 TET2 NCOA3 NCOA6 ARID1A CREBBP ARID2	1.24e-08	171	34	7	int:EGR2
Interaction	HNF4A interactions	PAXIP1 SREBF2 NCOA3 NCOA6 ARNT ARID1A CREBBP ARID2	1.45e-08	275	34	8	int:HNF4A
Interaction	TEAD1 interactions	PAXIP1 JUN ARNT ARID1A CREBBP MEF2D ARID2	1.52e-08	176	34	7	int:TEAD1
Interaction	ALG13 interactions	TNRC6B NCOA3 ARID1A ATXN2 FUBP3 CCNK YTHDF3	1.98e-08	183	34	7	int:ALG13
Interaction	PAX8 interactions	PAXIP1 TET2 NCOA3 ARID1A CREBBP MEF2D	2.89e-08	111	34	6	int:PAX8
Interaction	GATA2 interactions	PAXIP1 NCOA3 JUN NCOA6 ARID1A CREBBP ARID2	3.53e-08	199	34	7	int:GATA2
Interaction	FOS interactions	PAXIP1 NCOA3 JUN NCOA6 ARNT ARID1A CREBBP ARID2	3.86e-08	312	34	8	int:FOS
Interaction	FEV interactions	PAXIP1 NCOA3 NCOA6 ARNT ARID1A CREBBP ARID2	4.05e-08	203	34	7	int:FEV
Interaction	ETS1 interactions	PAXIP1 NCOA3 JUN ARID1A CREBBP ARID2	4.85e-08	121	34	6	int:ETS1
Interaction	PAX7 interactions	PAXIP1 NCOA3 ARNT ARID1A CREBBP MEF2D	5.61e-08	124	34	6	int:PAX7
Interaction	PAX9 interactions	PAXIP1 NCOA3 NCOA6 ARID1A FUBP3 MEF2D	7.44e-08	130	34	6	int:PAX9
Interaction	GCM1 interactions	PAXIP1 TET2 NCOA3 ARID1A CREBBP	9.71e-08	68	34	5	int:GCM1
Interaction	ETV4 interactions	PAXIP1 NCOA3 JUN ARID1A CREBBP	1.05e-07	69	34	5	int:ETV4
Interaction	NCOA2 interactions	FOXJ2 NCOA3 JUN NCOA6 ARNT CREBBP	1.21e-07	141	34	6	int:NCOA2
Interaction	PPIA interactions	PAXIP1 TNRC6B JUN NCOA6 ARID1A FUBP3 CCNK MED12 MEF2D ARID2 YTHDF3	1.29e-07	888	34	11	int:PPIA
Interaction	NCOA1 interactions	NCOA3 JUN NCOA6 ARNT ARID1A CREBBP	1.48e-07	146	34	6	int:NCOA1
Interaction	TP53BP1 interactions	PAXIP1 NCOA3 NCOA6 POU6F2 ARID1A NONO CREBBP MED12 CDK19	1.72e-07	533	34	9	int:TP53BP1
Interaction	MED23 interactions	PAXIP1 TNRC6B NCOA6 CREBBP CCNK MED12 CDK19	2.56e-07	266	34	7	int:MED23
Interaction	IRF4 interactions	PAXIP1 NCOA3 ARID1A MEF2D ARID2	2.99e-07	85	34	5	int:IRF4
Interaction	SMC5 interactions	ZNF384 JUN NCOA6 ARID1A ATXN2 NONO FUBP3 CCNK MEF2D ARID2 YTHDF3	4.24e-07	1000	34	11	int:SMC5
Interaction	TLX3 interactions	PAXIP1 TET2 NCOA3 NCOA6 POU6F2 ARID1A ARID2	4.69e-07	291	34	7	int:TLX3
Interaction	PIAS2 interactions	PAXIP1 SREBF2 JUN ARNT ZNF319 CREBBP	5.10e-07	180	34	6	int:PIAS2
Interaction	MEN1 interactions	PAXIP1 ZNF384 NCOA6 ARID1A NONO FUBP3 CCNK MED12 MEF2D ARID2 YTHDF3	5.64e-07	1029	34	11	int:MEN1
Interaction	JUN interactions	NCOA3 PACS1 JUN NCOA6 BATF3 ARNT CREBBP MEF2D	8.79e-07	470	34	8	int:JUN
Interaction	NFATC2 interactions	ZNF384 JUN ARID1A PRDM15 CREBBP MEF2D	9.46e-07	200	34	6	int:NFATC2
Interaction	RUNX1 interactions	PAXIP1 JUN ARID1A NONO CREBBP CCNK MED12	9.64e-07	324	34	7	int:RUNX1
Interaction	TBXT interactions	PAXIP1 NCOA3 NCOA6 ARID1A CREBBP	1.41e-06	116	34	5	int:TBXT
Interaction	DDIT3 interactions	JUN BATF3 ARID1A CREBBP ARID2	1.67e-06	120	34	5	int:DDIT3
Interaction	SOX2 interactions	PAXIP1 TET2 NCOA3 ZNF384 JUN NCOA6 ARNT ARID1A FUBP3 CCNK MEF2D ARID2	1.85e-06	1422	34	12	int:SOX2
Interaction	VDR interactions	NCOA3 JUN NCOA6 CREBBP MED12	2.21e-06	127	34	5	int:VDR
Interaction	MARF1 interactions	TNRC6B ATXN2 CREBBP FUBP3 YTHDF3	2.29e-06	128	34	5	int:MARF1
Interaction	TPRX2 interactions	PAXIP1 NCOA6 ARID1A CREBBP	2.33e-06	56	34	4	int:TPRX2
Interaction	TLE3 interactions	FOXJ2 TET2 NCOA3 ARNT ARID1A CREBBP ARID2	2.59e-06	376	34	7	int:TLE3
Interaction	EBF1 interactions	TET2 POU6F2 CREBBP	2.94e-06	17	34	3	int:EBF1
Interaction	SMARCC1 interactions	NCOA3 JUN ARID1A NONO CREBBP FUBP3 ARID2	2.98e-06	384	34	7	int:SMARCC1
Interaction	SMAD2 interactions	PAXIP1 NCOA3 JUN NCOA6 TOB1 ARID1A CREBBP	3.03e-06	385	34	7	int:SMAD2
Interaction	MAU2 interactions	TET2 NONO FUBP3 MED12 CDK19	3.09e-06	136	34	5	int:MAU2
Interaction	CPEB1 interactions	TNRC6B JUN ATXN2 FUBP3 YTHDF3	4.38e-06	146	34	5	int:CPEB1
Interaction	CREBBP interactions	SREBF2 NCOA3 JUN NCOA6 ARNT ARID1A NONO CREBBP	5.33e-06	599	34	8	int:CREBBP
Interaction	EGR1 interactions	SREBF2 JUN CREBBP ARID2	6.40e-06	72	34	4	int:EGR1
Interaction	TNRC6A interactions	TNRC6B NCOA6 ARID1A FUBP3 MED12 YTHDF3	6.61e-06	280	34	6	int:TNRC6A
Interaction	SMAD3 interactions	SREBF2 NCOA3 JUN NCOA6 TOB1 ARID1A CREBBP	8.07e-06	447	34	7	int:SMAD3
Interaction	YAP1 interactions	TNRC6B JUN NCOA6 ARNT ARID1A NONO CREBBP CCNK MED12 ARID2	8.53e-06	1095	34	10	int:YAP1
Interaction	RXRA interactions	NCOA3 NCOA6 NONO CREBBP MEF2D	8.93e-06	169	34	5	int:RXRA
Interaction	EPAS1 interactions	JUN BATF3 ARNT CREBBP MED12	1.00e-05	173	34	5	int:EPAS1
Interaction	TLX1 interactions	PAXIP1 NCOA3 ARID1A CREBBP MEF2D	1.06e-05	175	34	5	int:TLX1
Interaction	HOXD13 interactions	FOXJ2 JUN POU6F2 CREBBP	1.08e-05	82	34	4	int:HOXD13
Interaction	PPARG interactions	PAXIP1 NCOA3 JUN NCOA6 CREBBP ARID2	1.12e-05	307	34	6	int:PPARG
Interaction	ARID1B interactions	NCOA3 BATF3 ARID1A CREBBP ARID2	1.12e-05	177	34	5	int:ARID1B
Interaction	EP300 interactions	PAXIP1 SREBF2 NCOA3 JUN NCOA6 ARNT ARID1A NONO CREBBP FUBP3 MEF2D	1.13e-05	1401	34	11	int:EP300
Interaction	GSC interactions	PAXIP1 NCOA3 ARNT CREBBP	1.36e-05	87	34	4	int:GSC
Interaction	LHX3 interactions	PAXIP1 ARID1A CREBBP MEF2D ARID2	1.38e-05	185	34	5	int:LHX3
Interaction	GATA3 interactions	PAXIP1 NCOA3 ARID1A CREBBP FUBP3	1.46e-05	187	34	5	int:GATA3
Interaction	FOXI1 interactions	PAXIP1 NCOA3 ARID1A CREBBP	1.70e-05	92	34	4	int:FOXI1
Interaction	PML interactions	PAXIP1 TET2 TNRC6B JUN ARNT NONO CREBBP MEF2D YTHDF3	1.73e-05	933	34	9	int:PML
Interaction	MYOD1 interactions	PAXIP1 NCOA3 JUN ARID1A CREBBP	1.74e-05	194	34	5	int:MYOD1
Interaction	RBM47 interactions	TNRC6B ATXN2 PRR3 FUBP3 YTHDF3	2.22e-05	204	34	5	int:RBM47
Interaction	CNOT3 interactions	TNRC6B TOB1 CREBBP FUBP3 YTHDF3	2.38e-05	207	34	5	int:CNOT3
Interaction	RBMS1 interactions	TNRC6B ATXN2 PRR3 FUBP3 YTHDF3	2.38e-05	207	34	5	int:RBMS1
Interaction	NR3C1 interactions	PAXIP1 FOXJ2 NCOA3 JUN NCOA6 ARID1A NONO CREBBP ARID2	2.43e-05	974	34	9	int:NR3C1
Interaction	PIAS1 interactions	PAXIP1 SREBF2 NCOA3 JUN NONO CREBBP	2.46e-05	353	34	6	int:PIAS1
Interaction	NFIC interactions	PAXIP1 TET2 NCOA3 ARID1A CREBBP	2.55e-05	210	34	5	int:NFIC
Interaction	NR4A1 interactions	TNRC6B NCOA3 NONO FUBP3 YTHDF3	2.67e-05	212	34	5	int:NR4A1
Interaction	PAX6 interactions	PAXIP1 NCOA3 NCOA6 ARID1A CREBBP ARID2	3.01e-05	366	34	6	int:PAX6
Interaction	KLF1 interactions	ARID1A PRR3 CREBBP	3.28e-05	37	34	3	int:KLF1
Interaction	RARA interactions	NCOA3 NCOA6 ARID1A NONO CREBBP	3.40e-05	223	34	5	int:RARA
Interaction	THRA interactions	NCOA3 NCOA6 CREBBP MED12	3.56e-05	111	34	4	int:THRA
Interaction	CNOT11 interactions	TNRC6B TOB1 FUBP3 YTHDF3	3.69e-05	112	34	4	int:CNOT11
Interaction	TBR1 interactions	PAXIP1 TET2 NCOA3 ARID1A	3.82e-05	113	34	4	int:TBR1
Interaction	MEX3A interactions	SREBF2 JUN ARID1A CREBBP FUBP3 YTHDF3	3.94e-05	384	34	6	int:MEX3A
Interaction	CNOT9 interactions	TNRC6B TOB1 ATXN2 FUBP3 YTHDF3	4.02e-05	231	34	5	int:CNOT9
Interaction	PAN2 interactions	TET2 TNRC6B TOB1 NONO CREBBP YTHDF3	4.74e-05	397	34	6	int:PAN2
Interaction	NPAS2 interactions	NCOA3 ARNT CREBBP	4.81e-05	42	34	3	int:NPAS2
Interaction	SMAD1 interactions	TET2 NCOA6 TOB1 ARID1A CREBBP	5.12e-05	243	34	5	int:SMAD1
Interaction	TBP interactions	FOXJ2 NCOA3 JUN NCOA6 CREBBP	6.19e-05	253	34	5	int:TBP
Interaction	R3HDM2 interactions	TNRC6B ATXN2 FUBP3 YTHDF3	6.40e-05	129	34	4	int:R3HDM2
Interaction	WWTR1 interactions	TNRC6B NCOA6 ARNT ARID1A CREBBP ARID2	6.66e-05	422	34	6	int:WWTR1
Interaction	HELZ interactions	TNRC6B ATXN2 CREBBP FUBP3 YTHDF3	6.67e-05	257	34	5	int:HELZ
Interaction	HDAC1 interactions	TET2 TNRC6B JUN ARNT ARID1A NONO CREBBP MED12 MEF2D	6.68e-05	1108	34	9	int:HDAC1
Interaction	LSM14A interactions	TNRC6B ATXN2 FUBP3 YTHDF3 CDK19	7.05e-05	260	34	5	int:LSM14A
Interaction	NCOR2 interactions	NCOA3 JUN NCOA6 ARNT CREBBP	7.57e-05	264	34	5	int:NCOR2
Interaction	FOSB interactions	JUN POU6F2 CREBBP	7.67e-05	49	34	3	int:FOSB
Interaction	PHOX2A interactions	JUN CREBBP	7.69e-05	8	34	2	int:PHOX2A
Interaction	SOX15 interactions	PAXIP1 NCOA3 ARID1A ARID2	9.05e-05	141	34	4	int:SOX15
Interaction	CNOT10 interactions	TNRC6B TOB1 FUBP3 YTHDF3	9.05e-05	141	34	4	int:CNOT10
GeneFamily	Ataxins\|Trinucleotide repeat containing	PAXIP1 TNRC6B NCOA3 ZNF384 ATXN2 MED12	1.70e-12	25	29	6	775
GeneFamily	AT-rich interaction domain containing	ARID1A ARID2	2.57e-04	15	29	2	418
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA3 CREBBP	3.33e-04	17	29	2	486
GeneFamily	Basic helix-loop-helix proteins	SREBF2 NCOA3 ARNT	7.14e-04	110	29	3	420
GeneFamily	Cyclins\|Mediator complex	MED12 CDK19	1.27e-03	33	29	2	1061
GeneFamily	Basic leucine zipper proteins	JUN BATF3	2.79e-03	49	29	2	506
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF384 ZNF319 ZNF853 PRDM15	2.66e-02	718	29	4	28
Coexpression	GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	HOXD9 ATXN2 CREBBP MEF2D HCN1 CDK19	2.40e-07	199	35	6	M6987
Coexpression	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	SREBF2 FOXJ2 ZNF384 POU6F2 MED12	6.63e-06	200	35	5	M5168
Coexpression	MARKS_ACETYLATED_NON_HISTONE_PROTEINS	NCOA3 JUN	1.13e-04	12	35	2	M1160
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA3 JUN ATXN2 PRR3 CREBBP YTHDF3 CDK19	1.17e-04	856	35	7	M4500
Coexpression	GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN	FOXJ2 ARNT CREBBP STXBP5	1.17e-04	190	35	4	M8457
Coexpression	GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP	TNRC6B JUN STXBP5 MEF2D	1.25e-04	193	35	4	M4177
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP	TNRC6B TOB1 STXBP5 MEF2D	1.27e-04	194	35	4	M4192
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP	TNRC6B JUN TOB1 MEF2D	1.27e-04	194	35	4	M4187
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN	TET2 JUN ARID1A YTHDF3	1.40e-04	199	35	4	M9744
Coexpression	GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	FOXJ2 NCOA3 TOB1 CREBBP	1.43e-04	200	35	4	M5059
Coexpression	GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	HOXD9 ATXN2 CREBBP MEF2D	1.43e-04	200	35	4	M291
Coexpression	GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN	TNRC6B PACS1 ARID1A MEF2D	1.43e-04	200	35	4	M7441
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	NCOA3 NCOA6 ZNF853 FUBP3	1.13e-05	178	35	4	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXJ2 KCNN3 ZNF319 HOXD9	1.31e-05	185	35	4	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
Drug	Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; PC3; HT_HG-U133A	SREBF2 TNRC6B NCOA3 PACS1 ARNT CDK19	5.28e-07	198	35	6	2081_UP
Drug	AC1L2E0P	NCOA3 JUN NCOA6 NONO CREBBP MED12	6.68e-06	307	35	6	CID000019390
Drug	troglitazone; Down 200; 10uM; PC3; HG-U133A	TNRC6B PACS1 BATF3 ARID1A ATXN2	1.10e-05	193	35	5	431_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	SREBF2 TNRC6B CCNK MED12 CDK19	1.18e-05	196	35	5	1021_DN
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SREBF2 TNRC6B JUN MED12 CDK19	1.21e-05	197	35	5	7037_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	PACS1 JUN POU6F2 ARNT MEF2D	1.24e-05	198	35	5	2124_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SREBF2 TNRC6B ZNF384 ARNT MED12	1.27e-05	199	35	5	7009_DN
Drug	CV-1	SREBF2 NCOA3 JUN MED12 HCN1	1.77e-05	213	35	5	CID000130105
Drug	3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide	ARNT CREBBP	2.29e-05	5	35	2	ctd:C575894
Drug	glutamin	KCNN3 NCOA3 ZNF384 JUN ARID1A CREBBP	6.58e-05	461	35	6	CID000000738
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A	JUN ARNT CCNK MEF2D	1.34e-04	171	35	4	3297_UP
Drug	Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; HL60; HG-U133A	NCOA3 JUN MED12 CDK19	1.53e-04	177	35	4	1555_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA	PACS1 JUN ARNT CDK19	1.67e-04	181	35	4	1077_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	SREBF2 TNRC6B MED12 CDK19	1.78e-04	184	35	4	1081_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	JUN ARID1A CCNK CDK19	1.89e-04	187	35	4	5420_UP
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SREBF2 NCOA3 ARID1A CDK19	1.93e-04	188	35	4	4845_DN
Drug	Econazole nitrate [24169-02-6]; Up 200; 9uM; MCF7; HT_HG-U133A	SREBF2 JUN ARNT MEF2D	2.05e-04	191	35	4	6008_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HG-U133A	JUN ARNT ATXN2 MEF2D	2.05e-04	191	35	4	417_UP
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; HL60; HG-U133A	NCOA3 TOB1 ARID1A CDK19	2.05e-04	191	35	4	1563_UP
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SREBF2 ARNT MED12 MEF2D	2.13e-04	193	35	4	3200_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A	JUN ARID1A CREBBP CDK19	2.13e-04	193	35	4	2829_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A	JUN FUBP3 MED12 CDK19	2.13e-04	193	35	4	1547_UP
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	BATF3 ARNT ARID1A MEF2D	2.13e-04	193	35	4	6646_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	PACS1 JUN ARNT CDK19	2.13e-04	193	35	4	3250_UP
Drug	indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A	PACS1 JUN ARID1A CCNK	2.13e-04	193	35	4	262_UP
Drug	Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	BATF3 ARID1A MEF2D CDK19	2.18e-04	194	35	4	6647_DN
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PACS1 JUN ARNT CDK19	2.18e-04	194	35	4	7479_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	JUN ARID1A CCNK MED12	2.18e-04	194	35	4	1060_UP
Drug	Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A	SREBF2 JUN ARNT MED12	2.18e-04	194	35	4	3522_DN
Drug	semustine; Up 200; 100uM; MCF7; HT_HG-U133A	JUN ARNT CREBBP MEF2D	2.18e-04	194	35	4	7487_UP
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HG-U133A	NCOA3 HOXD9 ATXN2 CDK19	2.18e-04	194	35	4	1949_UP
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A	SREBF2 PACS1 ARNT MEF2D	2.22e-04	195	35	4	6101_DN
Drug	sodium 4-phenylbutyrate; Down 200; 1000uM; PC3; HG-U133A	BATF3 ARNT TOB1 CDK19	2.22e-04	195	35	4	434_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	ARNT ARID1A CCNK MEF2D	2.22e-04	195	35	4	3806_DN
Drug	Dacarbazine [4342-03-4]; Down 200; 22uM; HL60; HG-U133A	FOXJ2 ATXN2 FUBP3 MED12	2.22e-04	195	35	4	1762_DN
Drug	Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A	SREBF2 PACS1 JUN MED12	2.22e-04	195	35	4	3519_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	PACS1 ARNT CCNK MEF2D	2.26e-04	196	35	4	3790_DN
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SREBF2 PACS1 CCNK MED12	2.26e-04	196	35	4	3547_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	JUN ARNT ARID1A MED12	2.26e-04	196	35	4	1628_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A	TNRC6B JUN ARNT MEF2D	2.26e-04	196	35	4	2367_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; PC3; HT_HG-U133A	PACS1 ARNT ARID1A CCNK	2.26e-04	196	35	4	3720_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A	TNRC6B NCOA3 JUN MED12	2.31e-04	197	35	4	1564_UP
Drug	ICI 182,780; Down 200; 1uM; PC3; HG-U133A	NCOA3 JUN ATXN2 CDK19	2.31e-04	197	35	4	704_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA	TNRC6B ZNF384 JUN CDK19	2.31e-04	197	35	4	1042_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; HL60; HG-U133A	NCOA3 TOB1 ATXN2 FUBP3	2.31e-04	197	35	4	1980_DN
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A	SREBF2 PACS1 JUN ARID1A	2.31e-04	197	35	4	5353_UP
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SREBF2 TNRC6B JUN ARNT	2.35e-04	198	35	4	3446_DN
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; HL60; HT_HG-U133A	TNRC6B JUN ARNT CDK19	2.35e-04	198	35	4	1838_UP
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A	SREBF2 TNRC6B JUN ARNT	2.35e-04	198	35	4	7028_DN
Drug	Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A	SREBF2 JUN ARNT MED12	2.35e-04	198	35	4	7034_DN
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	PAXIP1 ZNF384 ARID1A CDK19	2.35e-04	198	35	4	5314_DN
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A	PACS1 POU6F2 ARNT MED12	2.35e-04	198	35	4	7024_UP
Drug	Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	PACS1 ARNT HOXD9 MEF2D	2.40e-04	199	35	4	2787_UP
Drug	Glipizide [29094-61-9]; Down 200; 9uM; PC3; HT_HG-U133A	SREBF2 PACS1 ARNT MEF2D	2.40e-04	199	35	4	6645_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A	SREBF2 FOXJ2 JUN ARNT	2.40e-04	199	35	4	3273_UP
Drug	Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A	SREBF2 TNRC6B PACS1 CDK19	2.40e-04	199	35	4	6312_DN
Drug	Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; PC3; HT_HG-U133A	TNRC6B NCOA3 PACS1 ZNF384	2.40e-04	199	35	4	6337_DN
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; HL60; HG-U133A	NCOA3 JUN TOB1 MED12	2.44e-04	200	35	4	2029_DN
Drug	3,3',4,5'-tetrahydroxystilbene	NCOA3 JUN ARNT	2.62e-04	81	35	3	ctd:C041525
Drug	Bestcall	JUN TOB1	2.72e-04	16	35	2	CID000002624
Drug	3-deazacytidine	NONO CCNK MED12 CDK19	2.74e-04	206	35	4	CID000001652
Drug	3'-dCTP	ARNT CREBBP HCN1	3.57e-04	90	35	3	CID000153054
Drug	AC1L1COZ	NCOA3 CREBBP MED12	3.57e-04	90	35	3	CID000001996
Disease	Sezary Syndrome	TET2 ARID1A CREBBP	4.01e-06	27	34	3	C0036920
Disease	Nephroblastoma	POU6F2 ARID1A NONO	9.72e-06	36	34	3	C0027708
Disease	oral squamous cell carcinoma (is_marker_for)	TET2 JUN ARID2	5.29e-05	63	34	3	DOID:0050866 (is_marker_for)
Disease	neutrophil percentage of leukocytes	FOXJ2 TET2 TNRC6B BATF3 ARID1A ATXN2	6.26e-05	610	34	6	EFO_0007990
Disease	Prostatic Neoplasms	TET2 NCOA3 ARID1A CREBBP MED12 ARID2	6.60e-05	616	34	6	C0033578
Disease	Malignant neoplasm of prostate	TET2 NCOA3 ARID1A CREBBP MED12 ARID2	6.60e-05	616	34	6	C0376358
Disease	alpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement	PACS1 CDK19	7.04e-05	11	34	2	EFO_0004357, EFO_0006870, EFO_0006883
Disease	alcohol use disorder (implicated_via_orthology)	SREBF2 ARID1A CREBBP ARID2	7.34e-05	195	34	4	DOID:1574 (implicated_via_orthology)
Disease	Coffin-Siris syndrome	ARID1A ARID2	9.97e-05	13	34	2	C0265338
Disease	myelodysplastic syndrome (implicated_via_orthology)	TET2 CREBBP	1.34e-04	15	34	2	DOID:0050908 (implicated_via_orthology)
Disease	Ischemic stroke, tissue plasminogen activator measurement	ATXN2 STXBP5	1.34e-04	15	34	2	EFO_0004791, HP_0002140
Disease	neutrophil count	FOXJ2 KCNN3 TET2 ARID1A ATXN2 CREBBP STXBP5 MEF2D	1.38e-04	1382	34	8	EFO_0004833
Disease	factor VIII measurement, Ischemic stroke	ATXN2 STXBP5	2.18e-04	19	34	2	EFO_0004630, HP_0002140
Disease	Liver carcinoma	SREBF2 JUN ARID1A HOXD9 ARID2	2.71e-04	507	34	5	C2239176
Disease	Colorectal Neoplasms	TET2 ARNT ARID1A HOXD9	2.82e-04	277	34	4	C0009404
Disease	Breast Carcinoma	SREBF2 NCOA3 JUN ARID1A MED12	3.56e-04	538	34	5	C0678222
Disease	Bilateral Wilms Tumor	ARID1A NONO	5.13e-04	29	34	2	C2930471
Disease	Ischemic stroke, von Willebrand factor measurement	ATXN2 STXBP5	5.49e-04	30	34	2	EFO_0004629, HP_0002140
Disease	colon cancer (is_implicated_in)	NCOA6 ARID1A	7.92e-04	36	34	2	DOID:219 (is_implicated_in)
Disease	Endometrioma	NCOA6 ARNT TOB1	8.43e-04	161	34	3	C0269102
Disease	Endometriosis	NCOA6 ARNT TOB1	8.43e-04	161	34	3	C0014175
Disease	lymphocyte percentage of leukocytes	TET2 BATF3 ARID1A ATXN2 STXBP5	9.27e-04	665	34	5	EFO_0007993
Disease	colonic neoplasm	TET2 TNRC6B	1.03e-03	41	34	2	EFO_0004288
Disease	Carcinoma, Transitional Cell	ARID1A CREBBP	1.03e-03	41	34	2	C0007138
Disease	colorectal cancer, endometrial neoplasm	TET2 ATXN2	1.08e-03	42	34	2	EFO_0004230, MONDO_0005575
Disease	birth weight	SREBF2 KCNN3 TET2 ATXN2	1.11e-03	399	34	4	EFO_0004344
Disease	hepatocellular carcinoma (is_implicated_in)	TET2 ARID1A ARID2	1.18e-03	181	34	3	DOID:684 (is_implicated_in)
Disease	coffee consumption measurement, tea consumption measurement	TET2 ATXN2	1.18e-03	44	34	2	EFO_0006781, EFO_0010091
Disease	fibrinogen measurement, tissue plasminogen activator measurement	ATXN2 STXBP5	1.24e-03	45	34	2	EFO_0004623, EFO_0004791
Disease	Malignant neoplasm of breast	SREBF2 NCOA3 JUN NCOA6 ARID1A MED12	1.29e-03	1074	34	6	C0006142
Disease	disorder of pharynx	TET2 ARNT	1.29e-03	46	34	2	MONDO_0020592
Disease	birth weight, parental genotype effect measurement	KCNN3 TET2 ATXN2	1.40e-03	192	34	3	EFO_0004344, EFO_0005939
Disease	sexual dimorphism measurement	TET2 PACS1 SEC16B NCOA6 ARID1A FUBP3	1.50e-03	1106	34	6	EFO_0021796
Disease	metabolic syndrome	SEC16B ARNT ARID1A	1.57e-03	200	34	3	EFO_0000195

Protein segments in the cluster

Peptide	Gene	Start	Entry
SEQHVQQPPAQQPGQ	ARNT	741	P27540
QNQHQQPTAPPQQAA	CDK19	376	Q9BWU1
VQQPIQQPQQPTQQS	ARID2	911	Q68CP9
RQQQQQHSPAPPPQQ	ARID2	1011	Q68CP9
DPQQPAQQQQPAQQP	CCNK	306	O75909
QPQVPGQQPAQPQTH	CREBBP	501	Q92793
NQPQPQPQQQSPEDD	BATF3	21	Q9NR55
AQPSYQQQPQSQPPQ	ARID1A	496	O14497
TQQHPQSQPPYSQPQ	ARID1A	541	O14497
AQSPYQQQQPQQPAP	ARID1A	556	O14497
PQQPPHPFSQQQQQQ	PAXIP1	441	Q6ZW49
QQLQFPQQQLHPPQQ	PAXIP1	466	Q6ZW49
SQALQHQVPPQQPPQ	PAXIP1	561	Q6ZW49
HQVPPQQPPQQQQQQ	PAXIP1	566	Q6ZW49
QQQQQQPPPSPQQHQ	PAXIP1	576	Q6ZW49
QQHHQQQQQQPPPPP	NONO	26	Q15233
AFPAQPQQQQQPPHH	JUN	196	P05412
PQQQQQPPHHLPQQM	JUN	201	P05412
QQQQQQQQPPPAAAN	ATXN2	181	Q99700
QQQQQPPHPLSQLAQ	KCNN3	76	Q9UGI6
QQPTQQVPSQQSQPQ	FUBP3	496	Q96I24
QHSQPQQQQLDPNNP	HOXD9	261	P28356
HQQQQQQQAAPPQPQ	MED12	2116	Q93074
PPQQSQPQQQQAPAQ	FOXJ2	311	Q9P0K8
AQSPQQPPPQQQQQQ	PACS1	26	Q6VY07
LQARPPQQHQQQQPQ	NCOA6	286	Q14686
PQQHQQQQPQGIRPQ	NCOA6	291	Q14686
PPPSQPQSQQQQQQQ	NCOA6	1016	Q14686
QQVQQSQPPQTQPQQ	HCN1	736	O60741
PNQNQSQNPNPNANQ	HS6ST2	541	Q96MM7
VTAWQQPQQPQQPQQ	MEF2D	361	Q14814
QPQQPPQQQSHLVPV	MEF2D	396	Q14814
SQPQAPPQQAAQPQV	PRDM15	1481	P57071
QQQQQQPPPSTNQHP	POU6F2	191	P78424
QLQQAPQPQQHQPHS	POU6F2	241	P78424
KQNHHQPPTQQQPPL	PRR3	6	P79522
QQQQQQTQAFSPPPN	NCOA3	1271	Q9Y6Q9
SQQQQQQHPPGNREP	STXBP5	21	Q5T5C0
QQGPQPQAQPHQVQP	YTHDF3	331	Q7Z739
PQAQPHQVQPQQQQL	YTHDF3	336	Q7Z739
QQQQQQPPPHFQSPG	ZNF384	511	Q8TF68
QPQPQPQTQLQQQTV	SREBF2	136	Q12772
PQPQQEPRADHQQQP	SEC16B	56	Q96JE7
SQQQPQQQQQPAQPP	TOB1	236	P50616
QQPEPQQQPQHEQLQ	ZNF853	96	P0CG23
QQQPQHEQLQQPQPH	ZNF853	101	P0CG23
QPQPHLELQQQPQQD	ZNF853	111	P0CG23
TQPQQPQPPQPQHHA	ZNF319	11	Q9P2F9
PQPQQQQRPQQQQPH	TET2	1536	Q6N021
WNKQHQQQQPPQQPP	TNRC6B	816	Q9UPQ9